Dr. Kiersten Stead is a Venture Principal at Monsanto Growth Ventures. Monsanto is a leading global, agricultural company providing products to growers worldwide. Monsanto Growth Ventures, through investment and partnership, encourages entrepreneurs and innovative start-up companies, to take on the challenge of a more sustainable future for world food production. Dr. Stead has over 15 years of experience in the Ag & Biotechnology space. Prior to joining Monsanto, Kiersten was on the Burrill & Company Venture Team which invested broadly in Life Sciences and Industrial Biotechnology with $1.5B AUM.
Kiersten was a Management Consultant specialized in early stage company development in nanotechnology, agriculture and materials engineering. She was a Scientist in Genetics & Molecular Biology at the University of Alberta and at Agriculture and Agri-Food Canada. She holds a Ph.D. in Molecular Biology & Genetics. In addition, she also holds an MBA in Finance from the University of Alberta, where she attended as the AHFMR ForeFront Scholar.
Early in her academic career she was a member of an Ag start-up that was acquired by Seaphire/ Arcadia Biosciences. She is currently on the board of two Scientific Granting agencies, and a Sport-not-for-profit.